TY  - RPRT
TI  - Validation and invalidation of SARS-CoV-2 main protease inhibitors using the Flip-GFP and Protease-Glo luciferase assays
AU  - Ma, C.
AU  - Tan, H.
AU  - Choza, J.
AU  - Wang, Y.
AU  - Wang, J.
PY  - 2021
DO  - 10.1101/2021.08.28.458041
UR  - https://www.biorxiv.org/content/10.1101/2021.08.28.458041v1
ID  - 10.1101/2021.08.28.458041
ER  -